Follow
Joel P. Wagner
Joel P. Wagner
Oncology Data Science, Novartis Institutes for BioMedical Research
Verified email at novartis.com
Title
Cited by
Cited by
Year
Systems analysis of EGF receptor signaling dynamics with microwestern arrays
MF Ciaccio, JP Wagner, CP Chuu, DA Lauffenburger, RB Jones
Nature methods 7 (2), 148-155, 2010
2352010
Eap1p, an Adhesin That Mediates Candida albicans Biofilm Formation In Vitro and In Vivo
F Li, MJ Svarovsky, AJ Karlsson, JP Wagner, K Marchillo, P Oshel, ...
Eukaryotic cell 6 (6), 931-939, 2007
1982007
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts
AL Grauel, B Nguyen, D Ruddy, T Laszewski, S Schwartz, J Chang, ...
Nature communications 11 (1), 6315, 2020
1222020
The tandem duplicator phenotype as a distinct genomic configuration in cancer
F Menghi, K Inaki, XY Woo, PA Kumar, KR Grzeda, A Malhotra, V Yadav, ...
Proceedings of the National Academy of Sciences 113 (17), E2373-E2382, 2016
992016
Receptor tyrosine kinases fall into distinct classes based on their inferred signaling networks
JP Wagner, A Wolf-Yadlin, M Sevecka, JK Grenier, DE Root, ...
Science signaling 6 (284), ra58-ra58, 2013
622013
Discovery and optimization of HKT288, a Cadherin-6–Targeting ADC for the treatment of ovarian and renal cancers
CU Bialucha, SD Collins, X Li, P Saxena, X Zhang, C Dürr, B Lafont, ...
Cancer discovery 7 (9), 1030-1045, 2017
502017
PTMScout, a Web resource for analysis of high throughput post-translational proteomics studies
KM Naegle, M Gymrek, BA Joughin, JP Wagner, RE Welsch, MB Yaffe, ...
Molecular & Cellular Proteomics 9 (11), 2558-2570, 2010
472010
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Y Wang, M Mohseni, A Grauel, JE Diez, W Guan, S Liang, JE Choi, M Pu, ...
Scientific reports 11 (1), 1399, 2021
462021
Systems consequences of amplicon formation in human breast cancer
K Inaki, F Menghi, XY Woo, JP Wagner, PÉ Jacques, YF Lee, ...
Genome research 24 (10), 1559-1571, 2014
372014
Signaling network state predicts twist-mediated effects on breast cell migration across diverse growth factor contexts
HD Kim, AS Meyer, JP Wagner, SK Alford, A Wells, FB Gertler, ...
Molecular & Cellular Proteomics 10 (11), 2011
322011
A phase 1 study of a CDH6-targeting antibody-drug conjugate in patients with advanced solid tumors with evaluation of inflammatory and neurological adverse events
P Schöffski, N Concin, C Suarez, V Subbiah, Y Ando, S Ruan, JP Wagner, ...
Oncology research and treatment 44 (10), 547-556, 2021
142021
A CRISPR screen reveals resistance mechanisms to CD3-bispecific antibody therapy
SQ Liu, A Grantham, C Landry, B Granda, R Chopra, S Chakravarthy, ...
Cancer immunology research 9 (1), 34-49, 2021
92021
PAX8 lineage-driven T cell engaging antibody for the treatment of high-grade serous ovarian cancer
E Lee, S Szvetecz, R Polli, A Grauel, J Chen, J Judge, S Jaiswal, ...
Scientific Reports 11 (1), 14841, 2021
42021
Bayesian network inference of phosphoproteomic signaling networks
J Wagner, D Lauffenburger
Seventh Annual Workshop on Bayes Applications, Montreal, Canada, 2009
32009
Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
JL Cotton, J Estrada Diez, V Sagar, J Chen, M Piquet, J Alford, Y Song, ...
Cancer Research 83 (21), 3611-3623, 2023
12023
Inferring copy number variation from gene expression data: methods, comparisons, and applications to oncology
J Boen, JP Wagner, N Di Nanni
bioRxiv, 2021.10. 18.463991, 2021
12021
Abstract PO-100: Expressed molecular barcoding coupled with single cell RNAseq enables a high resolution investigation into the evolution of drug tolerance
JL Cotton, VK Radhakrishna, JE Diez, DA Ruddy, K Sprouffske, G Boulay, ...
Cancer Research 80 (21_Supplement), PO-100-PO-100, 2020
2020
Expressed molecular barcoding coupled with single cell RNAseq enables a high resolution investigation into the evolution of drug tolerance.
JL Cotton, VK Radhakrishna, JE Diez, DA Ruddy, K Sprouffske, G Boulay, ...
CANCER RESEARCH 80 (21), 2020
2020
Abstract A122: Molecular barcoding and single cell approaches to investigate drug tolerance in EGFRmut NSCLC
JL Cotton, V KrishnamurthyRadhakrishna, J Chen, M Piquet, J Wagner, ...
Molecular Cancer Therapeutics 18 (12_Supplement), A122-A122, 2019
2019
Abstract B137: Oncogenic chromosomal blocks in cancer genomes.
JP Wagner, ET Liu
Molecular Cancer Therapeutics 12 (11_Supplement), B137-B137, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20